Benzinga's Top Upgrades
October 09, 2015 at 09:02 AM EDT
Credit Suisse upgraded Eli Lilly and Co (NYSE: LLY) from Neutral to Outperform. The price target for Eli Lilly has been raised from $89 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|